These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Trendelenburg M; Lopez-Trascasa M; Potlukova E; Moll S; Regenass S; Frémeaux-Bacchi V; Martinez-Ara J; Jancova E; Picazo ML; Honsova E; Tesar V; Sadallah S; Schifferli J Nephrol Dial Transplant; 2006 Nov; 21(11):3115-21. PubMed ID: 16877491 [TBL] [Abstract][Full Text] [Related]
3. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009 [TBL] [Abstract][Full Text] [Related]
4. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature. Baranowska-Daca E; Choi YJ; Barrios R; Nassar G; Suki WN; Truong LD Hum Pathol; 2001 Oct; 32(10):1125-35. PubMed ID: 11679948 [TBL] [Abstract][Full Text] [Related]
5. Potential for glomerular C4d as an indicator of thrombotic microangiopathy in lupus nephritis. Cohen D; Koopmans M; Kremer Hovinga IC; Berger SP; Roos van Groningen M; Steup-Beekman GM; de Heer E; Bruijn JA; Bajema IM Arthritis Rheum; 2008 Aug; 58(8):2460-9. PubMed ID: 18668574 [TBL] [Abstract][Full Text] [Related]
6. Repeated renal biopsy in proliferative lupus nephritis--predictive role of serum C1q and albuminuria. Gunnarsson I; Sundelin B; Heimbürger M; Forslid J; van Vollenhoven R; Lundberg I; Jacobson SH J Rheumatol; 2002 Apr; 29(4):693-9. PubMed ID: 11950009 [TBL] [Abstract][Full Text] [Related]
7. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534 [TBL] [Abstract][Full Text] [Related]
8. [The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis]. Zhang FC; Zhou B; Dong Y Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(14):955-9. PubMed ID: 16061001 [TBL] [Abstract][Full Text] [Related]
9. Hypocomplementemic urticarial vasculitis or systemic lupus erythematosus? Trendelenburg M; Courvoisier S; Späth PJ; Moll S; Mihatsch M; Itin P; Schifferli JA Am J Kidney Dis; 1999 Oct; 34(4):745-51. PubMed ID: 10516358 [TBL] [Abstract][Full Text] [Related]
10. [Significance of serum anti-Clq Ab in evaluation of lupus nephritis activity and its curative effects of pharmacotherapy on lupus nephritis]. Cai XY; Yang XY; Chen XH; Liang LQ; Guan MM; Qin SG; Fu JZ Zhonghua Yi Xue Za Zhi; 2004 Sep; 84(17):1436-9. PubMed ID: 15500738 [TBL] [Abstract][Full Text] [Related]
11. [C1q nephropathy. Report of one case]. Panuncio A; Alba A; Bacigalupe C; Caorsi H; Schwedt E; Otatti G; Saralegui P; Mariño A Rev Med Chil; 2008 Oct; 136(10):1307-10. PubMed ID: 19194628 [TBL] [Abstract][Full Text] [Related]
12. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
13. Predominant tubulointerstitial nephritis in a patient with systemic lupus nephritis. Mori Y; Kishimoto N; Yamahara H; Kijima Y; Nose A; Uchiyama-Tanaka Y; Fukui M; Kitamura T; Tokoro T; Masaki H; Nagata T; Umeda Y; Nishikawa M; Iwasaka T Clin Exp Nephrol; 2005 Mar; 9(1):79-84. PubMed ID: 15830279 [TBL] [Abstract][Full Text] [Related]
14. C1q nephropathy: do C1q deposits have any prognostic significance in the nephrotic syndrome? Davenport A; Maciver AG; Mackenzie JC Nephrol Dial Transplant; 1992; 7(5):391-6. PubMed ID: 1321373 [TBL] [Abstract][Full Text] [Related]
16. Anti-C1q autoantibodies in lupus nephritis. Sinico RA; Rimoldi L; Radice A; Bianchi L; Gallelli B; Moroni G Ann N Y Acad Sci; 2009 Sep; 1173():47-51. PubMed ID: 19758131 [TBL] [Abstract][Full Text] [Related]
17. Prolonged membranous lupus nephritis with change of anti-ssDNA antibody titer and repeated renal relapse. Yumura W; Suganuma S; Nitta K; Sano Y; Uchida K; Nihei H Clin Exp Nephrol; 2004 Dec; 8(4):363-8. PubMed ID: 15619038 [TBL] [Abstract][Full Text] [Related]
18. Overlapped glomerular lesions of chronic rejection and recurrent lupus nephritis in transplanted kidney: a case report. Masuzawa N; Urasaki K; Okamoto M; Nobori S; Ushigome H; Yoshimura N; Yanagisawa A Clin Transplant; 2011 Jul; 25 Suppl 23():49-52. PubMed ID: 21623915 [TBL] [Abstract][Full Text] [Related]
19. Clinical value of autoantibodies against C1q in children with glomerulonephritis. Kozyro I; Perahud I; Sadallah S; Sukalo A; Titov L; Schifferli J; Trendelenburg M Pediatrics; 2006 May; 117(5):1663-8. PubMed ID: 16651321 [TBL] [Abstract][Full Text] [Related]
20. Detection of anti-C1q antibodies and anti-C1q globular head domain antibodies in sera from Chinese patients with lupus nephritis. Tan Y; Zhou W; Yu F; Fang Q; Yang HZ; Zhao MH Mol Immunol; 2009 Jul; 46(11-12):2178-82. PubMed ID: 19481805 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]